Drs. Jared Weiss , Assistant Professor, Clinical Research Hematology/Oncology, University of North Carolina School of Medicine, and Josh Bauml , Assistant Professor of Medicine, Hospital of the University of Pennsylvania, join GRACE to discuss updates relating to pembrolizumab, nivolumab and PD-L1 markers for head and neck cancers.
Head and Neck Cancer
Head and Neck Cancer
Buddy Scalera is a podcaster and Senior Director of Content Strategy in Global Health Science at the Medicines Company, and has been a member of the...
In this thirteenth video, the fifth from the afternoon breakout survivorship sessions, GRACE presents Exercise for Lung Cancer Patients, with Jeffrey Eagan DPT.
In this twelfth video from the Targeted Therapy in Lung Cancer Live Patient Forum Webcast series, GRACE presents the afternoon breakout sessions. The fourth video from these sessions is Dealing with Down Days, presented by Jeanice Hansen, MSW, LCSW, OSW-C.
In this eleventh video from the Targeted Therapies in Lung Cancer Patient Forum, the third from the afternoon breakout survivorship sessions, GRACE presents Chemo Brain, with Denise Damek, MD.
ADL activities of daily living ANC absolute neutrophil count, the absolute number of bacterial infection fighting blood cells low means notably...
From the Grace Archives | Originally Published September 14, 2010 | By Moderators | Leave a comment The following content is offered by the...
From the Grace Archives | Originally Published September 3, 2010 | By Kelay Trentham | 4 Comments Kelay Trentham, a nutritionist with a particular...
From the Grace Archives | Originally Published September 2, 2010 | By Kelay Trentham | 6 Comments GRACE was fortunate enough to have Kelay Trentham,...
Cancer 101 FAQ: My oncologist told me my counts are low, so I need to delay my next chemo treatment? Is this going to be harmful?
From the Grace Archives | Originally Published September 27, 2010 | By Moderators | Leave a comment It’s not unusual to need to delay treatment and...
No Result Found